TNF-R2 expression in acquired middle ear cholesteatoma

Brazilian Journal of Otorhinolaryngology

Volumn 77, Issue 4, 2011, Pages 531-536

  Vitale, Rodrigo Faller ^c   Pereira, Celina Siqueira Barbosa ^a   Alves, Adriana Leal ^a   Fregnani, Jose Humberto Tavares Guerreiro ^b   Ribeiro, Fernando Quintanilha ^a  

^a Santa Casa de Sao Paulo School of Medicine   (Brazil)

^b A C CAMARGO CANCER CENTER   (Brazil)

^c School of Santa Casa de São Paulo ^*

Author keywords

Bone resorption; Cholesteatoma; Middle ear; Receptors; Tumor necrosis factor; Tumor necrosis factor alpha; Type ii

Indexed keywords

EID: 80052067565     PISSN: 18088694     EISSN: 18088686     Source Type: Journal    
DOI: 10.1590/S1808-86942011000400020     Document Type: Article

References (17)

1. Ribeiro FAQ, Pereira CSB. Otite média crônica colesteatomatosa In: SBORL. Tratado de Otorrinolaringologia. São Paulo: Editora Roca; 2003.p.93-102.
2. Alves AL, Pereira CSB, Ribeiro FAQ, Fregnani JHTG. Análise dos padrões histopatológicos do colesteatoma adquirido da orelha média. Braz J Otorhinolaryngol. 2008;74(6):835-41.
3. Lim DJ, Saunders WH. Acquired cholesteatoma: light and electron microscopic observation. Ann Otol. 1972;81:2-12.
4. Pereira CSB. Imunoexpressão da citoqueratina 16 e do antígeno nuclear Ki-67 no colesteatoma adquirido da orelha média. Tese (doutorado). São Paulo: Faculdade de Ciências Médicas da Santa Casa de São Paulo; 2001.
5. Kurihara A, Toshima M, Yuasa R, Takasaka T. Bone destruction mechanisms in chronic otitis media with cholesteatoma: specific production by cholesteatoma tissue in culture of bone-resorbing activity attributable to interleukin-1 alpha. Ann Otol Rhinol Laryngol. 1991;100(12):989-98.
6. Lessa HA, Freitas EB, Cruz OLM. Complicações das otites médias. In: SBORL. Tratado de otorrinolaringologia. São Paulo: Editora Roca; 2003. p 43-9.
7. Iino K, Toryama M, Ogawa H, Kawakami M. Cholesteatoma debris as an activator of human monocytes. Acta otolaryngol. 1990;110:410-5.
8. Kreutzer DL, Yellon RF, Leonard G, Marucha PT, Craven R, Carpenter RJ et al. Characterization of cytokines present in middle ear effusions. Laryngoscope. 1991;101:165-9.
9. Alves AL, Ribeiro FAQ. O papel das citocinas no colesteatoma adquirido da orelha média: revisão da literatura. Rev Bras Otorrinolaringol. 2004;70(6):813-8.
10. Vitale RF, Ribeiro FAQ. O papel do fator de necrose tumoral Alfa no processo de erosão óssea presente no colesteatoma adquirido da orelha média. Braz J Otorhinolaryngol. 2007;73(1):123-7.
11. Ramesh G, Reeves WB. TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure. Am J Physiol Renal Physiol. 2003;285(4):F610-8.
12. Abdo M, Hisheh S, Arfuso F, Dharmarajan A. The expression of tumor necrosis factor-alpha, its receptors and steroidogenic acute regulatory protein during corpus luteum regression. Reprod Biol Endocrinol. 2008;6:50-61.
13. Bingham CO. The pathogenesis of rheumatoid arthritis: pivotal citokynes involved in bone degradation and inflammation. J Reumatol Suppl. 2002;65:3-9
14. Amar MS; Wishahi HF; Zakhary MM. Clinical and biochemical studies of bone destruction in cholesteatoma. J Laryngol Otol. 1996;110(6):534-9.
15. Tos M. Pathology of the ossicular chain in various chronic middle ear diseases. J Laryngol Otol. 1979;93:769-80.
16. Dornelles C, Rosito LPS, Meurer L, Costa SS, Argenta A, Alves SL. Correlação da cadeia ossicular no transoperatório com achados histológicos de colesteatomas. Braz J Otorhinolaryngol. 2007;73(6):738-43.
17. Abbas AK, Lichtman AH, Pober JS. Citocinas. Imunologia celular e molecular. 2nd ed. Rio de Janeiro: Revinter;1998